Strata Critical Medical, Inc.

SRTANASDAQIndustrials● Active

$5.79

$-0.47(-7.51%)

Market Cap$500988840

P/E Ratio—

52W High$6.5

52W Low$3.51

Avg Volume836K

Open$6.25

Beta2.20

Free Cash Flow Financials Revenue

Strata Critical Medical, Inc. (SRTA) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

SRTA · free cash flow · updated Jun 8, 2026

Core FCF metrics

SRTA · FCF · TTM · margin & CAGR

Free cash flow was −$59.9M for FY2025 (fiscal year ending 2025-12-31), down 68.7% year-over-year The FCF margin was -30.4%.

FY2025 Free Cash Flow−$59.9M▼ -68.7% YoY

Trailing 12M (TTM)−$54.0Mtrailing 4 quarters sum

FCF Margin-30.4%−$59.9M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

SRTA · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest−$48.9M(11M)−$59.9M▼ 68.7%-30.4%

FY2024−$2.5M(33M)−$35.5M▼ 3.1%-14.3%

FY2023−$32.3M(2M)−$34.5M▲ +9.0%-15.3%

FY2022−$37.1M(1M)−$37.9M▼ 130.6%-25.9%

FY2021−$15.6M(1M)−$16.4M▼ 46.6%-32.5%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

SRTA · P/FCF · FCF yield · FCF per share

Strata Critical Medical, Inc. (SRTA) reported negative free cash flow of −$0.06B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

SRTA · cash flow statement · operating / investing / financing

For FY2025, Strata Critical Medical, Inc. generated −$48.9M in operating cash flow and spent 11M in capital expenditures, yielding −$59.9M in free cash flow.

Operating Activities

−$48.9M

Cash from core business operations

2025-12-31

Investing Activities

+$69.8M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$8.9M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF (−$48.9M) − |CapEx| (11M) = FCF (−$59.9M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Industrials)

SRTA vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Strata Critical Medical, Inc.YOU

SRTA

−$59.9M-68.7%-30.4%

Loss

Union Pacific Corporation

Industrials · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Strata Critical Medical, Inc. (SRTA) reported free cash flow of −$59.9M for FY2025 (fiscal year ending 2025-12-31), down 68.7% year-over-year. The FCF margin was -30.4%.

Strata Critical Medical, Inc. has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 7 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

SRTA free cash flow · 8 questions

Strata Critical Medical, Inc. free cash flow was −$59.9M for FY2025, down 68.7% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$54.0M.

SRTA free cash flowSRTA FCFSRTA FCF 2025SRTA free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Strata Critical Medical, Inc. · Strata Critical Medical, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026